Medical Technology, School of Allied Health Sciences, Walailak University, Thai Buri, Nakhon Si Thammarat, Thailand.
Department of Protozoology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Antioxid Redox Signal. 2024 Mar;40(7-9):460-469. doi: 10.1089/ars.2023.0306. Epub 2023 Aug 1.
It is still unclear how ascorbic acid levels relate to the pathogenesis of malaria. This systematic review synthesized different ascorbic acid levels in malaria patients with different severity levels of malaria and species. The systematic review protocol was registered in the PROSPERO database (CRD42023394849). A systematic search of PubMed, Embase, MEDLINE, Ovid, Scopus, and Google Scholar was conducted to identify studies that reported ascorbic acid and malaria. The pooled standardized mean difference (Cohen's ) with 95% confidence intervals (CIs) was calculated using the random-effects model. A total of 1480 articles were obtained from the searches of the databases, and 30 studies were included for syntheses. The meta-analysis revealed that patients with malaria had lower levels of ascorbic acid than those without malaria or uninfected controls ( < 0.01, Cohen's = -3.71, 95% CI = -4.44 to -2.98, = 98.87%, 30 studies). Comparable levels of ascorbic acid were observed between patients with severe malaria and those with nonsevere malaria ( = 0.06, Cohen's = -1.39, 95% CI = -2.85 to 0.07, = 96.58%, 4 studies). Similarly, levels of ascorbic acid were comparable between patients with and malaria ( = 0.34, Cohen's = -1.06, 95% CI = -3.23 to 1.12, = 97.30%, 3 studies). The meta-analysis reveals diminished levels of ascorbic acid in malaria cases. Manipulating the host's nutritional status, such as by supplementing it with ascorbic acid to restore reactive oxygen species balance, may alter the progression of malarial infection and prevention of disease severity. 40, 460-469.
目前仍不清楚抗坏血酸水平与疟疾发病机制之间的关系。本系统评价综合了不同严重程度疟疾患者和不同疟原虫种类的抗坏血酸水平。系统评价方案已在 PROSPERO 数据库(CRD42023394849)中注册。对 PubMed、Embase、MEDLINE、Ovid、Scopus 和 Google Scholar 进行了系统检索,以确定报告抗坏血酸和疟疾的研究。使用随机效应模型计算合并标准化均数差(Cohen's )和 95%置信区间(CIs)。从数据库检索中获得了 1480 篇文章,其中 30 项研究被纳入综合分析。Meta 分析显示,疟疾患者的抗坏血酸水平低于无疟疾或未感染对照者(<0.01,Cohen's =-3.71,95%CI=-4.44 至-2.98,=98.87%,30 项研究)。严重疟疾患者和非严重疟疾患者的抗坏血酸水平相当(=0.06,Cohen's =-1.39,95%CI=-2.85 至 0.07,=96.58%,4 项研究)。同样,间日疟原虫和恶性疟原虫患者的抗坏血酸水平相当(=0.34,Cohen's =-1.06,95%CI=-3.23 至 1.12,=97.30%,3 项研究)。Meta 分析显示,疟疾患者的抗坏血酸水平降低。通过操纵宿主的营养状态,例如通过补充抗坏血酸来恢复活性氧平衡,可能会改变疟原虫感染的进展和疾病严重程度的预防。